Home > Boards > US Listed > Biotechs > Neon Therapeutics (NTGN)

ack to News Results

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
m1999 Member Profile
Member Level 
Followed By 863
Posts 71,049
Boards Moderated 35
Alias Born 03/10/09
160x600 placeholder
Termination of Registration of a Class of Security Under Section 12(b) (15-12b) Edgar (US Regulatory) - 5/18/2020 6:09:23 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 5/6/2020 5:10:57 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 5/6/2020 5:04:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2020 4:47:18 PM
Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... Edgar (US Regulatory) - 5/6/2020 10:48:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2020 5:11:22 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/1/2020 8:39:04 AM
Neon Therapeutics Announces Acceptance of European Clinical Trial Authorization Application for NEO-PTC-01 GlobeNewswire Inc. - 4/30/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2020 5:33:24 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 4/29/2020 5:31:48 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/21/2020 4:31:49 PM
WeissLaw LLP Investigates Neon Therapeutics, Inc. PR Newswire (US) - 4/10/2020 7:45:00 PM
Proxy Statement - Merger or Acquistion (definitive) (defm14a) Edgar (US Regulatory) - 4/2/2020 5:00:12 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/2/2020 9:01:53 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 3/31/2020 5:10:59 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 3/31/2020 4:06:38 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 3/31/2020 7:56:45 AM
BioNTech Announces Full Year 2019 Financial Results and Corporate Update GlobeNewswire Inc. - 3/31/2020 6:42:46 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/27/2020 2:29:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/25/2020 5:29:39 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/23/2020 8:17:14 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2020 6:40:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2020 6:40:09 PM
m1999 Member Level  Friday, 09/06/19 06:42:14 AM
Re: None
Post # of 14 
ack to News Results
Neon Therapeutics Shares Rise on Publication in Scientific Journal
6:44 pm ET September 5, 2019 (Dow Jones) Print


By Dave Sebastian

Shares of Neon Therapeutics Inc. (NTGN) rose more than 14% in after-hours trading Thursday after the company published a paper in a scientific journal that details a process for predicting MHC class II cancer-specific neoantigens.
The paper, titled "Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction," was published in the scientific journal Immunity.
The company said predicting cancer-specific antigens is a precursor to developing immunotherapies that could destroy malignant cells.
Neon said it will integrate the MHC class II prediction tool into its RECON bioinformatics platform, which identifies and predicts neoantigen targets associated with a patient's tumor.

Write to Dave Sebastian at dave.sebastian@wsj.com


STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS

http://investorshub.advfn.com/boards/board.aspx?board_id=19627

My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences